Adherence Monitoring Package (AMoPac) in patients suspected of non-response to antihypertensive treatment: perceived usefulness by general practitioners.
Fine Michèle DietrichAndreas ZellerKurt E HersbergerIsabelle ArnetPublished in: BMJ open quality (2024)
AMoPac was rated as useful for identifying and excluding non-adherence in patients with hypertension and was highly accepted among patients. Including adherence data in clinical decision-making could contribute to optimising patient care.